At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Bronchodilators
- Mechanism of Action Apoptosis stimulants; Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 24 Jun 2001 No-Development-Reported for Cancer in France (Unknown route)
- 14 May 1997 Preclinical development for Cancer in France (Unknown route)